| NDC Code | 69097-533-02 |
|---|
| Package Description | 30 TABLET in 1 BOTTLE (69097-533-02) |
|---|
| Product NDC | 69097-533 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Tenofovir Disoproxil Fumarate |
|---|
| Non-Proprietary Name | Tenofovir Disoproxil Fumarate |
|---|
| Dosage Form | TABLET |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20180126 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA078800 |
|---|
| Manufacturer | Cipla USA Inc. |
|---|
| Substance Name | TENOFOVIR DISOPROXIL FUMARATE |
|---|
| Strength | 300 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS] |
|---|